5000万，“保健品一哥”投了家AI芯片公司
Quick Answer
Tao Chen Beijian, a leading health supplement company in China, announced a 50 million yuan investment in an AI chip company on June 18.
Quick Take
Tao Chen Beijian, a leading health supplement company in China, announced a 50 million yuan investment in an AI chip company on June 18. This strategic move highlights the growing intersection of health and technology sectors, as companies seek to leverage AI advancements for better product development.
Key Points
- Tao Chen Beijian is investing 50 million yuan in an AI chip firm.
- The investment aims to enhance product development through AI technology.
- This move signifies a trend of health companies integrating tech innovations.
- The announcement was made on June 18, 2023.
- AI advancements are increasingly relevant in the health supplement sector.
Article Excerpt
From source RSS / original summary芯东西（公众号：aichip001） 作者| ZeR0 编辑| 漠影. 芯东西6月22日报道，6月18日，国内“保健品一哥”汤臣倍健发布公告，宣布拟以自有资金5000万元投资
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from WebSearch (Tavily)
See more →Frontier Labs, Chinese Model Vendors & the Compute Bottleneck ...
In H1 2026, the AI model landscape is dominated by the Anthropic-OpenAI duopoly, with Anthropic's Claude Code leading in coding agents. This shift highlights a compute bottleneck affecting vendors relying on older models, as performance metrics increasingly favor newer architectures.
